ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1300

$402K Total Retail Price of All Prescriptions

Rank: 68 out of 1300

590 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,963 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LISINOPRIL 470 434 1 2
SIMVASTATIN 386 354 2 3
AMLODIPINE BESYLATE 374 356 3 6
FUROSEMIDE 314 288 4 8
LEVOTHYROXINE SODIUM 285 244 5 1
WARFARIN SODIUM 264 260 6 9
METOPROLOL TARTRATE 234 223 7 11
OMEPRAZOLE 222 208 8 4
METOPROLOL SUCCINATE 208 180 9 24
METFORMIN HCL 203 165 10 7
GABAPENTIN 189 130 11 15
ATENOLOL 176 171 12 12
HYDROCHLOROTHIAZIDE 167 157 13 10
CITALOPRAM HBR 161 144 14 19
TRAMADOL HCL 151 122 15 17
HYDROCODONE-ACETAMINOPHEN 151 98 S3 15 5
ATORVASTATIN CALCIUM 120 106 17 13
LOSARTAN POTASSIUM 116 99 18 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 102 19 21
ALLOPURINOL 102 85 20 29
POTASSIUM CHLORIDE 99 99 21 18
DIGOXIN 91 91 22 48
FLUTICASONE PROPIONATE 82 66 23 30
TRAZODONE HCL 79 64 24 34
ALENDRONATE SODIUM 75 62 25 20
PROPRANOLOL HCL 74 48 26 116
PRAVASTATIN SODIUM 74 64 26 23
TRIAMTERENE-HCTZ 68 65 28 54
KLOR-CON M20 67 65 29 60
DONEPEZIL HCL 65 65 30 32
DILTIAZEM ER 64 60 31 154
CYMBALTA 60 55 32 44
LANTUS 57 56 33 43
ISOSORBIDE MONONITRATE ER 57 57 33 82
LOVASTATIN 57 51 33 22
DOXAZOSIN MESYLATE 56 55 36 71
ADVAIR DISKUS 55 42 37 41
SPIRONOLACTONE 55 50 37 55
TAMSULOSIN HCL 52 52 39 25
PAROXETINE HCL 51 41 40 59
MIRTAZAPINE 50 50 41 50
PANTOPRAZOLE SODIUM 50 43 41 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.